GlassScriptPhysician profile
Edward B Savage
NPI 1528030731
$19,674.64
in general payments reported to CMS, 2019-2025
15 companies · $610 in 2025
The $610 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $866 · 2020: $12K · 2021: $18.44 · 2022: $1,605 · 2023: $707 · 2024: $3,578 · 2025: $610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,252 · Travel and Lodging: $1,629 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,251.50 |
| Travel and Lodging | $1,629.36 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,383.89 | 2019-2024 | |
| Edwards Lifesciences Corporation | $3,376.84 | 2019-2025 | Mitris Resilia Mitral Valve, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Carpentier-Edwards Physio Annuloplasty Ring With Holder - Mitral |
| Atricure, INC. | $1,039.34 | 2019-2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Abiomed | $629.18 | 2019-2025 | Impella |
| Abbott Laboratories | $286.78 | 2020-2023 | Navitor |
| Boston Scientific Corporation | $260.36 | 2022-2025 | General - Therapies |
| Medtronic, INC. | $179.18 | 2024-2025 | Signet, Corevalve Evolut R |
| Livanova USA, INC. | $117.62 | 2024 | Essenz |
| Dilon Technologies, INC. | $83.62 | 2024 | Hemoblast Bellows |
| Baxter Healthcare | $75.07 | 2022-2023 | Tisseel |
| Angiodynamics, INC. | $67.88 | 2019 | |
| Getinge USA Sales, LLC | $67.53 | 2021-2024 | Vasoview Hemopro 2 |
| Astrazeneca Pharmaceuticals LP | $53.38 | 2025 | |
| Artivion, INC. | $34.57 | 2019 | |
| Covidien LP | $19.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Savage listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.